Cargando…
Chemically-Boosted Corneal Cross-Linking for the Treatment of Keratoconus through a Riboflavin 0.25% Optimized Solution with High Superoxide Anion Release
The purpose of this study was to evaluate the effectiveness and safety of a novel buffered riboflavin solution approved for corneal cross-linking (CXL) in progressive keratoconus and secondary corneal ectasia. Following the in vivo preclinical study performed on New Zealand rabbits comparing the nov...
Autores principales: | Mazzotta, Cosimo, Ferrise, Marco, Gabriele, Guido, Gennaro, Paolo, Meduri, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004796/ https://www.ncbi.nlm.nih.gov/pubmed/33806928 http://dx.doi.org/10.3390/jcm10061324 |
Ejemplares similares
-
Progressive high-fluence epithelium-on accelerated corneal crosslinking: a novel corneal photodynamic therapy for early progressive keratoconus
por: Mazzotta, Cosimo, et al.
Publicado: (2023) -
Transepithelial Enhanced Fluence Pulsed Light M Accelerated Crosslinking for Early Progressive Keratoconus with Chemically Enhanced Riboflavin Solutions and Air Room Oxygen
por: Mazzotta, Cosimo, et al.
Publicado: (2022) -
Riboflavin-Ultraviolet A Corneal Cross-linking for Keratoconus
por: El-Raggal, Tamer M.
Publicado: (2009) -
A Comparative Study of 0.25% Levobupivacaine, 0.25% Ropivacaine, and 0.25% Bupivacaine in Paediatric Single Shot Caudal Block
por: Sharma, Jagdeep, et al.
Publicado: (2018) -
Comment on: Corneal collagen cross-linking with riboflavin and ultraviolet: A light for keratoconus
por: Parthasarathy, Anand
Publicado: (2010)